FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4364376089> ?p ?o ?g. }

• W4364376089 endingPage "100706" @default.
• W4364376089 startingPage "100706" @default.
• W4364376089 abstract "COVID-19 resulted in loss of human lives owing to respiratory failure caused by dysregulated immune system. Though many treatments are evaluated, the most appropriate is yet to be established. To determine the safety and efficacy of Siddha add-on therapy in COVID -19 in terms of accelerated recovery, reduced hospital stay & mortality and follow up assessment of post discharge status until 90 days as compared to the Standard Care management. In a randomized, controlled, single-center, open-label trial conducted on 200 hospitalized COVID-19 patients, they were allocated equally to be treated with add-on Siddha regimen with Standard care or only Standard care. Standard care was in accordance to the Government norms. Recovery was defined as amelioration of symptoms, viral clearance and attaining SpO2 > 94% in room air indicating the derived score of zero on WHO clinical progression scale. The primary and secondary end points were accelerated recovery (≤ 7 days) and mortality comparison between the groups respectively. Also, disease duration, length of hospital stays and laboratory parameters were assessed for safety and efficacy. Patients were followed through for 90 days after admission. In this study the accelerated recovery was 59.0% and 27.0% in treatment and control groups (ITT analyses) (p < 0.001) respectively and Odds for it were four times higher in the treatment group (OR: 3.9; 95% CI: 1.9, 8.0). The estimated median time for recovery in the treatment group was 7 days (95% CI: 6.0, 8.0; p=0.003) and 10 days (95% CI: 8.7, 11.3) in control. Hazard ratio for death in control was 2.3 times that of treatment group. No adverse reactions or alarming laboratory values were observed in response to intervention. In Severe COVID treatment group (n=80), mortality was 15.0% and 39.5% in control (n=81). The COVID stage progression was 65% less in test group. Mortality during treatment and 90 days follow up in Severe COVID patients were 12 (15%) and 35 (43.2%) in treatment and control groups respectively. The selected Siddha regimen when co-administered with Standard of Care have demonstrated that they can synergistically act to improve oxygenation status of patients, enhance the recovery rate from COVID-19 and reduce the mortality better when compared to administration of only Standard of Care. CTRI/2020/06/025768 Registered on: 09/06/2020." @default.
• W4364376089 created "2023-04-12" @default.
• W4364376089 creator A5009213345 @default.
• W4364376089 creator A5009684049 @default.
• W4364376089 creator A5019234790 @default.
• W4364376089 creator A5019974869 @default.
• W4364376089 creator A5020542744 @default.
• W4364376089 creator A5027970414 @default.
• W4364376089 creator A5033647491 @default.
• W4364376089 creator A5039990013 @default.
• W4364376089 creator A5043258501 @default.
• W4364376089 creator A5044130317 @default.
• W4364376089 creator A5069101121 @default.
• W4364376089 creator A5070853011 @default.
• W4364376089 creator A5079164862 @default.
• W4364376089 creator A5080231930 @default.
• W4364376089 creator A5087954036 @default.
• W4364376089 creator A5088188349 @default.
• W4364376089 date "2023-03-01" @default.
• W4364376089 modified "2023-09-27" @default.
• W4364376089 title "Safety and efficacy of Siddha management as adjuvant care for COVID-19 patients admitted in a tertiary care hospital - An open-label, proof-of-concept Randomized Controlled Trial" @default.
• W4364376089 cites W1990166011 @default.
• W4364376089 cites W2121615890 @default.
• W4364376089 cites W2991899552 @default.
• W4364376089 cites W3008461878 @default.
• W4364376089 cites W3008827533 @default.
• W4364376089 cites W3013967887 @default.
• W4364376089 cites W3016044084 @default.
• W4364376089 cites W3018023298 @default.
• W4364376089 cites W3024893910 @default.
• W4364376089 cites W3027432876 @default.
• W4364376089 cites W3027630905 @default.
• W4364376089 cites W3036812160 @default.
• W4364376089 cites W3043165632 @default.
• W4364376089 cites W3082355253 @default.
• W4364376089 cites W3093165877 @default.
• W4364376089 cites W3096398321 @default.
• W4364376089 cites W3096521880 @default.
• W4364376089 cites W3114193501 @default.
• W4364376089 cites W3119880982 @default.
• W4364376089 cites W3123314688 @default.
• W4364376089 cites W3126588149 @default.
• W4364376089 cites W3126663694 @default.
• W4364376089 cites W3136171392 @default.
• W4364376089 cites W3153745434 @default.
• W4364376089 cites W3170129628 @default.
• W4364376089 cites W3172706442 @default.
• W4364376089 cites W3184373227 @default.
• W4364376089 cites W3195977920 @default.
• W4364376089 cites W4210642183 @default.
• W4364376089 cites W4226004814 @default.
• W4364376089 cites W4241771140 @default.
• W4364376089 doi "https://doi.org/10.1016/j.jaim.2023.100706" @default.
• W4364376089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37197717" @default.
• W4364376089 hasPublicationYear "2023" @default.
• W4364376089 type Work @default.
• W4364376089 citedByCount "0" @default.
• W4364376089 crossrefType "journal-article" @default.
• W4364376089 hasAuthorship W4364376089A5009213345 @default.
• W4364376089 hasAuthorship W4364376089A5009684049 @default.
• W4364376089 hasAuthorship W4364376089A5019234790 @default.
• W4364376089 hasAuthorship W4364376089A5019974869 @default.
• W4364376089 hasAuthorship W4364376089A5020542744 @default.
• W4364376089 hasAuthorship W4364376089A5027970414 @default.
• W4364376089 hasAuthorship W4364376089A5033647491 @default.
• W4364376089 hasAuthorship W4364376089A5039990013 @default.
• W4364376089 hasAuthorship W4364376089A5043258501 @default.
• W4364376089 hasAuthorship W4364376089A5044130317 @default.
• W4364376089 hasAuthorship W4364376089A5069101121 @default.
• W4364376089 hasAuthorship W4364376089A5070853011 @default.
• W4364376089 hasAuthorship W4364376089A5079164862 @default.
• W4364376089 hasAuthorship W4364376089A5080231930 @default.
• W4364376089 hasAuthorship W4364376089A5087954036 @default.
• W4364376089 hasAuthorship W4364376089A5088188349 @default.
• W4364376089 hasBestOaLocation W43643760891 @default.
• W4364376089 hasConcept C126322002 @default.
• W4364376089 hasConcept C156957248 @default.
• W4364376089 hasConcept C168563851 @default.
• W4364376089 hasConcept C197934379 @default.
• W4364376089 hasConcept C203092338 @default.
• W4364376089 hasConcept C2781413609 @default.
• W4364376089 hasConcept C535046627 @default.
• W4364376089 hasConcept C71924100 @default.
• W4364376089 hasConceptScore W4364376089C126322002 @default.
• W4364376089 hasConceptScore W4364376089C156957248 @default.
• W4364376089 hasConceptScore W4364376089C168563851 @default.
• W4364376089 hasConceptScore W4364376089C197934379 @default.
• W4364376089 hasConceptScore W4364376089C203092338 @default.
• W4364376089 hasConceptScore W4364376089C2781413609 @default.
• W4364376089 hasConceptScore W4364376089C535046627 @default.
• W4364376089 hasConceptScore W4364376089C71924100 @default.
• W4364376089 hasIssue "2" @default.
• W4364376089 hasLocation W43643760891 @default.
• W4364376089 hasLocation W43643760892 @default.
• W4364376089 hasLocation W43643760893 @default.
• W4364376089 hasOpenAccess W4364376089 @default.
• W4364376089 hasPrimaryLocation W43643760891 @default.
• W4364376089 hasRelatedWork W2034542604 @default.

• next